A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Pancreatic cancer is one of the hardest cancers to treat, which makes early detection so crucial, now AI is lending a hand to speed up the process.

Could your dental hygiene routine hold the secret to warding off one of the most lethal cancers?

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

My 87-year-old mother has pancreatic cancer. My husband and I moved out of state to live with her for four months while she ...

India, March 11 -- Depleting a clotting protein from the liver may help slow pancreatic cancer, according to a new study ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.

FREDERICK, Md. ( DC News Now) — For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer. Frederick Health is the first in the U.S. to bring this ...

Alisa Clever, 37-year-old wife and mom of two is fighting for her life and needs support. A Bingo and Basket Raffle ...